Clinical Use of Incretin-Based Therapy in Type 2 Diabetes Mellitus- List the pros and cons of incretin-based therapies. Differentiate the clinical effects of glucagon-like peptide-1 receptor (GLP-1R) agonists from those of dipeptidyl peptidase 4 (DPP-4) inhibitors. Address common barriers to GLP-1R agonist therapy so as to improve patient adherence.
1.0 Free Contact Hours for Nurse Practitioners which includes 0.1 Hours of Pharmacology
Expires 12/7/12